DB3, LLC (FKA THE DASCHLE GROUP)

Lobbying for FRESENIUS KABI USA, LLC · Manufacturer of essential medicines and technologies

Filing Registration

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Jul 28, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Illinois

Lobbying activity 1

Health Issues

Issues related to domestic manufacturing of essential medicines; issues related to access to and availability of generic medicines, generally.

Foreign interests disclosed 1

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

FRESENIUS SE KGA

Germany · Bad Homburg · owns 100% of the client · contributed $0.00

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.